Raymond Sanchez, M.D. is a Life Sciences Executive and Board Member currently serving as a Senior Advisor at Bain Capital Life Sciences and holding positions on various boards and advisory committees. Previously the Chief Medical Officer at Cerevel Therapeutics, they focused on innovative treatments in CNS prior to its acquisition by AbbVie in August 2024. With over twenty years of experience across academia, medicine, and the pharmaceutical industry, Raymond has a strong track record in global asset development and regulatory approvals for drugs, including Abilify MyCite. They trained in Psychiatry at the Yale School of Medicine, where they were appointed Chief Resident, and are acknowledged as a significant clinical innovator, having been named to the PharmaVoice 100 in 2023.
This person is not in the org chart
This person is not in any teams
This person is not in any offices